ICD-10-CM 2027 diagnosis code
H47.522Disorders of visual pathways in (due to) neoplasm, left side
H47.522 is a valid, billable ICD-10-CM code for disorders of visual pathways in (due to) neoplasm, left side. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About H47.522
H47.522 is the ICD-10-CM diagnosis code for disorders of visual pathways in (due to) neoplasm, left side. It belongs to category H47 (other disorders of optic [2nd] nerve and visual pathways), block H46-H47 (disorders of optic nerve and visual pathways) and chapter 7 (diseases of the eye and adnexa). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
Within H47.52 (disorders of visual pathways in (due to) neoplasm), H47.522 is specifically for disorders of visual pathways in (due to) neoplasm, left side. Related codes cover right side (H47.521) and unspecified side (H47.529).
As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.
In MS-DRG v44.0, it is part of the grouping logic for DRG 091 (Other Disorders of Nervous System with MCC, relative weight 1.7046), DRG 092 (Other Disorders of Nervous System with CC, relative weight 1.0239) and DRG 093 (Other Disorders of Nervous System without CC/MCC, relative weight 0.7783), in MDC 01 (Diseases and Disorders of the Nervous System), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Before ICD-10, this condition was coded in ICD-9-CM as 377.61 (disorders of other visual pathways associated with neoplasms).
Notes that apply from higher levels
Instructions written at a parent level also apply to H47.522.
› From H47.5 Disorders of other visual pathways
- underlying condition
Broader instructions also apply from Chapter 7: Diseases of the eye and adnexa.
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 01 · Diseases and Disorders of the Nervous System
ICD-9-CM equivalent
Converter →- 377.61Disorders of other visual pathways associated with neoplasmsapproximate
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about H47.522
Is H47.522 billable?
- Yes. H47.522 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can H47.522 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict H47.522 as a principal diagnosis.
Is H47.522 a CC or MCC?
- H47.522 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.
What DRG does H47.522 group to?
- H47.522 is used in the MS-DRG v44.0 logic for MS-DRG 091 (Other Disorders of Nervous System with MCC), MS-DRG 092 (Other Disorders of Nervous System with CC) and MS-DRG 093 (Other Disorders of Nervous System without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.
What is the ICD-9 code for H47.522?
- The CMS General Equivalence Mappings map H47.522 to ICD-9-CM 377.61.